Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men
Primary Purpose
Overweight and Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Juice Plus
Sponsored by

About this trial
This is an interventional prevention trial for Overweight and Obesity focused on measuring Male, Overweight, Juice Plus
Eligibility Criteria
Inclusion Criteria:
- Male age 25-75 years
- Healthy (no known diabetes mellitus, cardiovascular disease, or eating disorder)
- Non-smoker
- Overweight (BMI ≥25) with central adiposity as indicated by waist circumference (≥102 cm).
- Endothelial dysfunction with high-fat meal
Exclusion Criteria:
- Use of lipid-lowering or antihypertensive medications, unless stable on medication for at least 3 months and willing to refrain from taking medication for 12 hours prior to EF scanning;
- Regular use of multivitamins and/or complementary or alternative supplement therapy (including all Juice Plus+® products) and unwillingness to discontinue supplementation for at least 8 weeks prior to study initiation and for study duration
- Anticipated inability to complete or comply with study protocol;
- Diagnosed eating disorder
- Any rheumatologic disease requiring regular use of NSAIDs or alternative medications
- Regular use of fiber supplements
- Use of insulin, glucose sensitizing medication, or vasoactive medication
- Substance abuse (chronic alcoholism, or other chemical dependency
- Pre-existing cardiovascular disease.
Sites / Locations
- Yale-Griffin Prevention Research Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Juice Plus
Placebo
Arm Description
Juice Plus is the combination of Juice Plus+® Garden Blend, Juice Plus+® Orchard Blend and Juice Plus+® Vineyard Blend.
The placebo consists of microcrystalline cellulose,dicalcium phosphate, magnesium stearate, and FD & C yellow #6.
Outcomes
Primary Outcome Measures
Endothelial Function
Brachial artery flow mediated dilation (FMD)
Secondary Outcome Measures
Weight
Waist Circumference
Blood pressure
Serum biomarker measures
These samples will be used to assess participants' biomarkers of oxidative stress (i.e. oxidized LDL levels, lipid hydroperoxides, and protein carbonyls) and compliance measure (i.e. serum carotenoids)
Full Information
NCT ID
NCT01533987
First Posted
August 9, 2011
Last Updated
February 15, 2012
Sponsor
Griffin Hospital
Collaborators
NSA, LLC
1. Study Identification
Unique Protocol Identification Number
NCT01533987
Brief Title
Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men
Official Title
Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men: A Randomized, Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2011
Overall Recruitment Status
Completed
Study Start Date
July 2009 (undefined)
Primary Completion Date
July 2010 (Actual)
Study Completion Date
August 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Griffin Hospital
Collaborators
NSA, LLC
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to determine the effects of daily ingestion of Juice Plus+® capsules containing Orchard, Garden and Vineyard blends on endothelial function and biomarkers of oxidative stress (oxidized LDL, lipid hydroperoxides and protein carbonyls) in overweight men as compared to the placebo group.
Detailed Description
The prevalence of obesity in both adults and children in the United States has increased significantly over the past 50 years. More than 66% of adults in the US are now overweight or obese and at least 17% of children in the population at large are now considered overweight. Obesity may be a factor predisposing patients to a myriad of different comorbidities that increase the associated mortality rate. Several large prospective trials have documented that obesity is an independent risk factor for all-cause mortality from cardiovascular disease (CVD). Considering the major metabolic and biochemical changes that occur in obesity, such as atherogenic dyslipidemia, insulin resistance and hyperinsulinemia, endothelial dysfunction, and chronic inflammatory and prothrombotic states, obesity plays a role in the pathogenesis of systemic atherosclerosis and its clinical complications. Antioxidants are thought to help preserve the endothelium's capacity to generate NO, which acts to promote vasodilation, stabilize platelets, and promote the anti-inflammatory abilities of the endothelium. Juice Plus+® Capsules containing Orchard, Garden and Vineyard blends are rich in the traditional antioxidants β-carotene, Vitamin E and Vitamin C along with other carotenoids and phytonutrients. There is increasing attention to the possibility that micronutrients may exert health effects in concert. Outcomes in studies of isolated micronutrients, such as vitamin E, have often been often disappointing. Plant-derived micronutrients have the potential to contribute to vascular health by offering the endothelium protection from oxidative stress. Evidence of this anticipated effect would have implications for strategies to prevent or retard cardiovascular disease. Endothelial function testing using high-frequency ultrasound imaging of the brachial artery to assess endothelium-dependent flow-mediated dilatation (FMD) offers a non-invasive, uniquely valuable means of assessing aggregated influences on cardiac risk by gauging a physiologic response of the vascular endothelium. Proposed, therefore, is a randomized, double-blinded and placebo-controlled clinical trial of Juice Plus+® on endothelial function in overweight men with central adiposity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity
Keywords
Male, Overweight, Juice Plus
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Juice Plus
Arm Type
Experimental
Arm Description
Juice Plus is the combination of Juice Plus+® Garden Blend, Juice Plus+® Orchard Blend and Juice Plus+® Vineyard Blend.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
The placebo consists of microcrystalline cellulose,dicalcium phosphate, magnesium stearate, and FD & C yellow #6.
Intervention Type
Dietary Supplement
Intervention Name(s)
Juice Plus
Intervention Description
Juice Plus is the combination of Juice Plus+® Garden Blend, Juice Plus+® Orchard Blend and Juice Plus+® Vineyard Blend.
Primary Outcome Measure Information:
Title
Endothelial Function
Description
Brachial artery flow mediated dilation (FMD)
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Weight
Time Frame
8 weeks
Title
Waist Circumference
Time Frame
8 weeks
Title
Blood pressure
Time Frame
8 weeks
Title
Serum biomarker measures
Description
These samples will be used to assess participants' biomarkers of oxidative stress (i.e. oxidized LDL levels, lipid hydroperoxides, and protein carbonyls) and compliance measure (i.e. serum carotenoids)
Time Frame
8 weeks
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male age 25-75 years
Healthy (no known diabetes mellitus, cardiovascular disease, or eating disorder)
Non-smoker
Overweight (BMI ≥25) with central adiposity as indicated by waist circumference (≥102 cm).
Endothelial dysfunction with high-fat meal
Exclusion Criteria:
Use of lipid-lowering or antihypertensive medications, unless stable on medication for at least 3 months and willing to refrain from taking medication for 12 hours prior to EF scanning;
Regular use of multivitamins and/or complementary or alternative supplement therapy (including all Juice Plus+® products) and unwillingness to discontinue supplementation for at least 8 weeks prior to study initiation and for study duration
Anticipated inability to complete or comply with study protocol;
Diagnosed eating disorder
Any rheumatologic disease requiring regular use of NSAIDs or alternative medications
Regular use of fiber supplements
Use of insulin, glucose sensitizing medication, or vasoactive medication
Substance abuse (chronic alcoholism, or other chemical dependency
Pre-existing cardiovascular disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David L Katz, MD, MPH
Organizational Affiliation
Yale-Griffin Prevention Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale-Griffin Prevention Research Center
City
Derby
State/Province
Connecticut
ZIP/Postal Code
06418
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men
We'll reach out to this number within 24 hrs